Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold

Fig. 3

Effect of confirming and excluding power of clinical arguments on the post-test probability of TB, shown on a base-10 logarithmic scale and the corresponding probability scale. Ln: lymphadenopathy; pos: positive; neg: negative. The figure shows two Y-axis: one axis shows the log10 odds scale and the second axis shows the corresponding probabilities. Very strong, strong, good, or weak confirming power allows to advance, respectively, 2, 1.5, 1, 0.5 or 0 steps upward on the log10 odds scale, and thus results in a higher post-test probability. Similarly, the excluding power of an argument allows to regress downward and thus results in a lower post-test probability. Patient A presented without lymphadenopathy, had a positive CXR, and a positive Xpert. The pre-test probability (prevalence) was 17%. When converted to an odds, this equals 0.2. The log10 of that odds is −0.7. The absence of lymphadenopathy has an excluding power of 1, thus has no effect on the probability. Signs of TB on a CXR has weak confirming power: move 0.5 step upward: −0.7 + 0.5 = −0.2). A positive Xpert has very strong power: −0.2 + 2 = 1.8. After converting 1.8 log10 odds to odds, then to a probability, this patient has about 98% post-test probability of TB. The use of the log10 odds scale has been published elsewhere [13]. Patient B presented with lymphadenopathy, had a negative CXR, and a negative Xpert. In this patient the post-test probability of TB is about 2%

Back to article page